World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
12594
World Ranking
2959
National Ranking
1392

Overview

Kazutoyo Miura is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research activity spans multiple fields, primarily Medicine and Immunology and Microbiology, with a significant focus on Public Health, Environmental and Occupational Health, Immunology, Molecular Biology, Virology, and Infectious Diseases.

The central themes of Miura's work include Malaria Research and Control, Mosquito-borne diseases and control, vaccines and immunoinformatics approaches, Complement system in diseases, HIV Research and Treatment, Computational Drug Discovery Methods, and Invertebrate Immune Response Mechanisms.

Miura has contributed to several recent scientific publications, including:

  • Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination, 2021, Med
  • Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein, 2021, mSphere
  • Plasmodium falciparum -specific IgM B cells dominate in children, expand with malaria, and produce functional IgM, 2021, The Journal of Experimental Medicine
  • Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors, 2021, Cell Reports Medicine
  • Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses, 2022, Immunity

Frequent collaborators in their research include Carole A. Long, Ababacar Diouf, Simon J. Draper, Sarah E. Silk, and Angela M. Minassian.

Miura's work has been published extensively in several scientific venues. The most frequent publication platforms are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • npj Vaccines
  • Nature Communications
  • Vaccines

Best Publications

  • Erratum: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

    A D Douglas;A R Williams;J J Illingworth;G Kamuyu

  • Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

    Yimin Wu;Ruth D. Ellis;Donna Shaffer;Erica Fontes

  • The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

    Alexander D. Douglas;Andrew R. Williams;Joseph J. Illingworth;Gathoni Kamuyu

  • Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.

    Elissa M. Malkin;Anna P. Durbin;David J. Diemert;Jetsumon Sattabongkot

  • The Plasmodium falciparum-Specific Human Memory B Cell Compartment Expands Gradually with Repeated Malaria Infections

    Greta E Weiss;Boubacar Zan Traoré;Kassoum Kayentao;Aissata Ongoiba

  • Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines

    Kazutoyo Miura;Andrew C. Orcutt;Olga V. Muratova;Louis H. Miller

  • ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans

    Susanne H Sheehy;Christopher J A Duncan;Sean C Elias;Prateek Choudhary

  • A PfRH5-Based Vaccine Is Efficacious against Heterologous Strain Blood-Stage Plasmodium falciparum Infection in Aotus Monkeys

    Alexander D. Douglas;G. Christian Baldeviano;Carmen M. Lucas;Luis A. Lugo-Roman

  • A Randomized Controlled Phase 2 Trial of the Blood Stage AMA1-C1/Alhydrogel Malaria Vaccine in Children in Mali

    Issaka Sagara;Alassane Dicko;Ruth D. Ellis;Michael P. Fay

  • Immunity to Recombinant Plasmodium falciparum Merozoite Surface Protein 1 (MSP1): Protection in Aotus nancymai Monkeys Strongly Correlates with Anti-MSP1 Antibody Titer and In Vitro Parasite-Inhibitory Activity

    Sanjay Singh;Kazutoyo Miura;Hong Zhou;Olga Muratova

  • Phase Ia Clinical Evaluation of the Plasmodium Falciparum Blood-Stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors

    Susanne H Sheehy;Christopher J A Duncan;Sean C Elias;Katharine A Collins

  • Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors

    Susanne H. Sheehy;Christopher J. A. Duncan;Sean C. Elias;Sumi Biswas

  • Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays.

    Kazutoyo Miura;Bingbing Deng;Gregory Tullo;Ababacar Diouf

  • The heme biosynthesis pathway is essential for Plasmodium falciparum development in mosquito stage but not in blood stages.

    Hangjun Ke;Paul A. Sigala;Kazutoyo Miura;Joanne M. Morrisey

  • Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.

    Daniel G.W. Alanine;Doris Quinkert;Rasika Kumarasingha;Shahid Mehmood

  • Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions

    Ruth O. Payne;Sarah E. Silk;Sean C. Elias;Kazutoyo Miura

  • Enhancing Blockade of Plasmodium falciparum Erythrocyte Invasion: Assessing Combinations of Antibodies against PfRH5 and Other Merozoite Antigens

    Andrew R. Williams;Alexander D. Douglas;Kazutoyo Miura;Joseph J. Illingworth

  • Naturally acquired antibodies specific for plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria

    Tuan M. Tran;Aissata Ongoiba;Jill Coursen;Cecile Crosnier

  • Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate

    Andreas Martin Lisewski;Joel P. Quiros;Caroline L. Ng;Anbu Karani Adikesavan

  • Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.

    Angela M. Minassian;Sarah E. Silk;Jordan R. Barrett;Carolyn M. Nielsen

  • Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria.

    Gregory E. D. Mullen;Ruth D. Ellis;Kazutoyo Miura;Elissa Malkin

Frequent Co-Authors

Carole A. Long
Carole A. Long National Institute of Allergy and Infectious Diseases
Louis H. Miller
Louis H. Miller National Institute of Allergy and Infectious Diseases
Simon J. Draper
Simon J. Draper University of Oxford
Rick M. Fairhurst
Rick M. Fairhurst AstraZeneca (United Kingdom)
David L. Narum
David L. Narum National Institutes of Health
Allan Saul
Allan Saul Burnet Institute
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Ogobara K. Doumbo
Ogobara K. Doumbo University of Bamako
Takafumi Tsuboi
Takafumi Tsuboi Ehime University
Gavin J. Wright
Gavin J. Wright Wellcome Sanger Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open up diverse career opportunities. Accelerated nursing programs are an excellent option for those looking to quickly transition into nursing. These programs offer a fast-track pathway and often provide flexible online options tailored to busy schedules. If you’re seeking a more accessible entry point, there are numerous lpn schools easy to get into, which can help you build foundational clinical skills before advancing further.

For those aiming to advance their practice and take on greater responsibilities, understanding what is the easiest np program can guide you toward nurse practitioner degrees that fit your lifestyle and career goals without overwhelming demands. Additionally, specializing in mental health is a growing field, and researching the best online pmhnp programs with best clinical placement rates can ensure you receive quality training and meaningful hands-on experience essential for success.

These pathways complement Immunology studies by blending scientific knowledge with clinical practice, preparing graduates for impactful roles in healthcare settings. The variety of online degree options accommodates different learning styles and timelines, making it easier to pursue meaningful careers in nursing and related health sciences.

Best Scientists Citing Kazutoyo Miura

Trending Scientists

Recently Published Articles